No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: comment by Joob and Wiwanitkit
- PMID: 32404340
- DOI: 10.1136/annrheumdis-2020-217665
No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: comment by Joob and Wiwanitkit
Keywords: epidemiology; hydroxychloroquine; lupus erythematosus, systemic.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Romão et al and 'SLE patients are not immune to COVID-19: importance of sending the right message across' by Goyal.Ann Rheum Dis. 2021 Feb;80(2):e24. doi: 10.1136/annrheumdis-2020-217695. Epub 2020 May 13. Ann Rheum Dis. 2021. PMID: 32404341 No abstract available.
-
Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients.Ann Rheum Dis. 2021 May;80(5):e75. doi: 10.1136/annrheumdis-2020-218068. Epub 2020 Jun 19. Ann Rheum Dis. 2021. PMID: 32561608 No abstract available.
Comment on
-
SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment.Ann Rheum Dis. 2020 Jun;79(6):e61. doi: 10.1136/annrheumdis-2020-217506. Epub 2020 Apr 15. Ann Rheum Dis. 2020. PMID: 32295787 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
